Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer

Molecular and Clinical Oncology
Yasuyoshi MiyataHideki Sakai

Abstract

Cigarette smoking is a major risk factor for urothelial cancer (UC) development. However, the associations between smoking and changes in the pathological characteristics and molecular expression of cancer-related molecules in upper tract (UT) UC have not been fully elucidated. We investigated the associations between smoking status and cancer-related factors, including cancer cell proliferation, apoptosis, angiogenesis, lymphangiogenesis and expression of vascular endothelial growth factor-A and -C, matrix metalloproteinase (MMP)-2 and -9, cyclooxygenase (COX)-2 and urokinase-type plasminogen activator, in patients with UTUC. A total of 134 patients who underwent nephroureterectomy were retrospectively investigated. Proliferation index (PI), microvessel density and lymphatic vessel density (LVD) were measured using anti-Ki-67, anti-CD105 and anti-D2-40 antibodies in formalin-fixed specimens. The apoptotic index was evaluated using the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method. Other cancer-related molecules were investigated by immunohistochemistry in similar specimens. The patients were divided into three groups; non-smoker (n=54, 40.3%), former smoker (n=46, 34.3%) and current smoker (n=34,...Continue Reading

References

Apr 15, 1988·International Journal of Cancer. Journal International Du Cancer·O M JensenB L Sørensen
Feb 25, 2005·American Journal of Reproductive Immunology : AJRI·Derrick LaneSubbi P Mathur
Aug 30, 2005·European Journal of Pharmacology·Yi N YeChi H Cho
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yasuyoshi MiyataHiroshi Kanetake
Dec 22, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Xi ChenZhengtang Chen
Jun 25, 2010·Annals of Surgical Oncology·Priyanka SrivastavaRama D Mittal
Aug 6, 2010·Cancer Biology & Therapy·Christian Bolenz, Yair Lotan
Sep 29, 2011·International Journal of Clinical Oncology·Morihiko InamineYoichi Aoki
Jun 28, 2012·International Journal of Oncology·Yoshihiro MoritaToshiyuki Yoneda
Jun 30, 2012·European Urology·Michael RinkUNKNOWN Upper Tract Urothelial Carcinoma Collaboration
Jul 5, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Petra LenzLee E Moore
Jun 1, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ja Hyeon KuSang Eun Lee
Jul 3, 2013·European Urology·Joseph J CrivelliShahrokh F Shariat
Aug 27, 2013·Virchows Archiv : an International Journal of Pathology·Yasuyoshi MiyataHideki Sakai
Dec 24, 2013·Urologic Oncology·Jost von HardenbergChristian Bolenz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis